155 related articles for article (PubMed ID: 9258244)
1. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion.
Raine CS
J Neuroimmunol; 1997 Aug; 77(2):135-52. PubMed ID: 9258244
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
Wolswijk G
Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
[TBL] [Abstract][Full Text] [Related]
3. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion.
Raine CS
Ann Neurol; 1994; 36 Suppl():S61-72. PubMed ID: 8017891
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
[TBL] [Abstract][Full Text] [Related]
5. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
6. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
7. NF-κB Activation Protects Oligodendrocytes against Inflammation.
Stone S; Jamison S; Yue Y; Durose W; Schmidt-Ullrich R; Lin W
J Neurosci; 2017 Sep; 37(38):9332-9344. PubMed ID: 28842413
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
Dhib-Jalbut S
Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.
Raine CS; Scheinberg L; Waltz JM
Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526
[TBL] [Abstract][Full Text] [Related]
10. MS CD49d
Piatek P; Namiecinska M; Domowicz M; Przygodzka P; Wieczorek M; Michlewska S; Lewkowicz N; Tarkowski M; Lewkowicz P
Cells; 2019 Nov; 8(12):. PubMed ID: 31775315
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord.
Wolswijk G
Brain; 2002 Feb; 125(Pt 2):338-49. PubMed ID: 11844734
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocytes in the early course of multiple sclerosis.
Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules.
Lee SC; Raine CS
J Neuroimmunol; 1989 Dec; 25(2-3):261-6. PubMed ID: 2479662
[TBL] [Abstract][Full Text] [Related]
16. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
Henderson AP; Barnett MH; Parratt JD; Prineas JW
Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
[TBL] [Abstract][Full Text] [Related]
18. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
19. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
Dulamea AO
Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
[TBL] [Abstract][Full Text] [Related]
20. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.
Lucchinetti C; Brück W; Parisi J; Scheithauer B; Rodriguez M; Lassmann H
Brain; 1999 Dec; 122 ( Pt 12)():2279-95. PubMed ID: 10581222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
